Securities Code: 300149
Securities Abbreviation: Ruizhi Medicine
Announcement Number: 2026-35
Ruizhi Medicine Technology Co., Ltd.
Resolution Announcement of the 19th Meeting of the Sixth Board of Directors
The Company and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or significant omissions.
The 19th meeting of the Sixth Board of Directors of Ruizhi Medicine Technology Co., Ltd. (hereinafter referred to as the "Company") was held via communication on June 12, 2026. The meeting notice was delivered in writing, by phone, or by email. Six directors were expected to attend, and six directors actually attended. The meeting was presided over by Mr. WOO SWEE LIAN, Chairman of the Company. Senior management personnel of the Company attended the meeting as non-voting participants. The convening and holding of this meeting comply with relevant laws, administrative regulations, departmental rules, and the "Articles of Association." After careful deliberation by the attending directors, the following resolutions were formed:
I. Deliberated and passed the "Proposal on Adjusting the Issuance Price and Issuance Quantity of Shares to Specific Objects"
To better protect the interests of small and medium investors and in conjunction with the Company's actual situation, based on the relevant content of the Company's 2024 plan for issuing shares to specific objects, the Company has made corresponding adjustments to the pricing benchmark date, issuance price, and issuance quantity for this issuance to specific objects. The details are as follows:
- Adjustment of Issuance Price